美国缓刑或假释成年人中的乙型肝炎和丙型肝炎：2015-2018 年。
Hepatitis B and Hepatitis C among Adults on Probation or Parole in the United States: 2015-2018.
出版信息
J Health Care Poor Underserved. 2021;32(2):671-679. doi: 10.1353/hpu.2021.0096.
BACKGROUND
Viral hepatitis is highly prevalent in U.S. prison populations, but prevalence has not been described among adults on probation/parole.
METHODS
National Survey on Drug Use and Health data from 2015-2018 were pooled to estimate the prevalence of self-reported diagnosed hepatitis B or hepatitis C among adults reporting past-year parole vs. past-year probation only.
RESULTS
About 6.4% of adults on parole reported a diagnosis of hepatitis B or hepatitis C, which was significantly higher than adults on probation only (3.2%). The prevalence for both these groups was significantly higher than for adults not on probation/parole (1.3%).
CONCLUSIONS
Adults on probation/parole were more likely to self-report a medical diagnosis of hepatitis B or hepatitis C compared with adults not on probation/parole. This population may be challenging to reach, but viral hepatitis interventions could improve the health of a vulnerable group and prevent transmission from prison populations to the community.
背景
病毒性肝炎在美国监狱人群中高度流行，但在缓刑/假释的成年人中尚未描述其流行情况。
方法
对 2015-2018 年全国毒品使用和健康调查数据进行了汇总，以估计报告过去一年获得假释与仅报告过去一年缓刑的成年人中，自我报告确诊乙型肝炎或丙型肝炎的比例。
结果
约有 6.4%的假释成年人报告患有乙型肝炎或丙型肝炎，这明显高于仅缓刑的成年人（3.2%）。这两个群体的患病率都明显高于未缓刑/假释的成年人（1.3%）。
结论
与未缓刑/假释的成年人相比，缓刑/假释的成年人更有可能自我报告乙型肝炎或丙型肝炎的医学诊断。这一人群可能难以接触，但病毒性肝炎干预措施可以改善弱势群体的健康状况，并防止监狱人群向社区传播。
Zotero 插件